HIV Snippets: A Podcast Series

Antiretroviral therapy (ART) has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already-diverse field of HIV treatment. In this CE activity, participants will listen to expert faculty in a series of six podcasts. The faculty of this program will explore various aspects of HIV management, including recent guideline revisions, use of 2-drug regimens, individualizing ART regimens in patients with HIV and comorbidities, as well as the management of patients with HIV who are highly treatment-experienced. In addition, the potential use of long-acting injectable ART formulations in patients with HIV who struggle with stigma and/or adherence as well as advances in pre-exposure prophylaxis are examined.

Cost: Free

View Offer chevron_right

Key Features

  • Free
  • 1.50 AMA PRA Category 1 Credit(s)™
  • 1.5 contact hours of ACPE Continuing Education Credit
  • 43% of activities take less than 30 minutes to complete
  • The My Healio CME Dashboard keeps track of earned credits and saved activities
  • Personalized recommendations make finding your next activity easy
  • Over 50,000 of your colleagues know that earn credits is faster and easier with Healio CME

Topics Covered

  • HIV management
  • Antiretroviral therapy (ART)
  • Guideline revisions
  • 2-drug regimes
  • Comorbidities
  • Stimga
  • Adherence
  • Pre-exposure prophylaxis

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

-Interpret recent guideline revisions regarding the use of antiretroviral therapy (ART) in different patient populations.
-Examine current and prospective use of 2-drug regimens in the treatment of HIV.
-Incorporate individualized ART regimens to improve outcomes in patients with HIV and comorbidities.
-Utilize ART regimens that improve outcomes in highly treatment-experienced patients with HIV.
-Examine the potential use of long-acting injectable ART formulations in patients with HIV who struggle with stigma and/or adherence to prescribed regimens.
-Evaluate practice-based advances that may improve the consistent use of pre-exposure prophylaxis (PrEP).

Target Audience

The intended audience for this activity is infectious disease specialists, internists, pharmacists, and other health care professionals involved in the management of patients with HIV.

Additional credit info

This continuing medical education activity is provided by Vindico Medical Education.

This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is acceptable for 1.5 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is 0482-0000-20-013-H02-P, effective 11/30/2020. This is a knowledge-based activity and there is no fee to attend.

This enduring material is approved for 1 year from the date of original release, November 30, 2020, through November 29, 2021.

Stay up-to-date

Receive special offers, keep up with MOC requirements and stay informed of the latest offerings in free online CME in your specialty.